NDC product
Leader Allergy Relief D
NDC 70000-0042 · Cardinal Health 110, LLC. dba Leader
Key facts
| Product NDC | 70000-0042 |
|---|---|
| Proprietary name | Leader Allergy Relief D |
| Nonproprietary name | Cetirizine hydrochloride, Pseudoephedrine hydrochloride |
| Substances | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Cardinal Health 110, LLC. dba Leader |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA210719 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Mar 9, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: